|
Post by lakers on Oct 15, 2017 2:37:01 GMT -5
Afrezza News: Could New Labeling Change the Game? Written by Mike Hoskins and Amy Tenderich Published on October 10, 2017 www.healthline.com/diabetesmine/afrezza-inhaled-insulin-new-labelingExcerpts follow. The Future for Afrezza (?) With recent news of Novo's Fiasp approval helping MannKind compare the fast action of both insulins, and with both Dexcom CGM and the newly-approved Abbott FreeStyle Libre allowing more real-time data comparison, Castagna sees this as an especially exciting time for this Afrezza label change to happen. "It's important for us," he says. "While it may seem simple on the surface, I would highlight that just being able to understand what a 4-unit cartridge does... is key. It's the first time a doctor will be able to really see and understand, and that's really important when you think of your child or loved one going to bed, and not seeing nocturnal hypoglycemia or sugars running high. To be able to know your sugars will comfortably come down over a certain period of time is really important. We think that's critical as we go forward." Aside from these label changes, MannKind says it also recently dosed its first pediatric patient in the clinical trials setting (in collaboration with JDRF), and is exploring a 2-unit cartridge as a possibility for kids down the road. The company also just filed for regulatory approval in Brazil, as the first international country to start selling this inhaled insulin globally. Importantly, MannKind also said it's continuing conversations with payers for increased access, and the company expects this label change to help motivate more payers to put Afrezza on the formulary for patients. Improved access will be a crucial step in all of this, Castagna says. We're happy to hear of this progress for MannKind, and hope for the best on everything related to Afrezza. This product works well for us (both 'Mine editor AmyT and I myself use it), and we certainly continue keeping our fingers crossed that Afrezza becomes an option for anyone who wants it. Whether this label change is really the trigger remains to be seen.
|
|
|
Post by sayhey24 on Oct 15, 2017 7:47:33 GMT -5
Its good to see Steve Edelman and Gary Scheiner mentioned in the article. We should be hearing about the long awaited Edelman Ondou protocol soon.
|
|
|
Post by cjm18 on Oct 15, 2017 9:24:28 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 15, 2017 9:41:28 GMT -5
"The company also just filed for regulatory approval in Brazil, as the first international country to start selling this inhaled insulin globally."
MannKind or the Brazilian company filed?
|
|
|
Post by agedhippie on Oct 15, 2017 20:22:41 GMT -5
"The company also just filed for regulatory approval in Brazil, as the first international country to start selling this inhaled insulin globally." MannKind or the Brazilian company filed? BIOMM have filed for approval on the Regular insulin they are buying from Poland, although that was back in January. There have been no notification that they have filed for Afrezza yet.
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 16, 2017 21:36:43 GMT -5
Its good to see Steve Edelman and Gary Scheiner mentioned in the article. We should be hearing about the long awaited Edelman Ondou protocol soon. Edelman Ondou protocol? Please tell me more. Is Edelman developing an Afrezza protocol?
|
|
|
Post by dreamboatcruise on Oct 16, 2017 22:02:30 GMT -5
Its good to see Steve Edelman and Gary Scheiner mentioned in the article. We should be hearing about the long awaited Edelman Ondou protocol soon. Edelman Ondou protocol? Please tell me more. Is Edelman developing an Afrezza protocol? Here's a link to a discussion about Onduo. It talks about a "platform" rather than a "protocol". I think there is a fair amount of speculation but it seems no definitive news from the company. I don't believe they've started any clinical trials. www.healthline.com/diabetesmine/sanofi-and-verily-form-onduo#1
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 17, 2017 21:36:21 GMT -5
Edelman Ondou protocol? Please tell me more. Is Edelman developing an Afrezza protocol? Here's a link to a discussion about Onduo. It talks about a "platform" rather than a "protocol". I think there is a fair amount of speculation but it seems no definitive news from the company. I don't believe they've started any clinical trials. www.healthline.com/diabetesmine/sanofi-and-verily-form-onduo#1Thanks for that article, DBC. A glucose-sensing contact lense would be really cool, but it doesn't look like they have any real diabetes solutions going there. Nothing that compares with Afrezza and VDEX protocol.
|
|